SEC Form 4 · accession 0001127602-17-031767
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Dorman
Director
Period of report
Nov 8, 2017
Accepted (ET)
Nov 9, 2017 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 8, 2017 | A | 4,131 | $68.99 | A | 80,338 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share CreditsF2 | $0.00 | holding | — | — | — | — | — | Common Stock | 16,560 | 16,560 | D |
Explanation of responses
- F1Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
- F2Consists of deferred stock compensation payable pursuant to Reporting Person's election.